Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pedigree Analysis01:35

Pedigree Analysis

Overview
Genetic Lingo01:11

Genetic Lingo

Overview

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Geriatric Age is an Independent Risk Factor for Worse Clinical Outcomes After Motorcycle Collision.

The Journal of surgical research·2026
Same author

Age or Frailty: What Predicts Outcomes in Geriatric Patients With Rib Fractures?

The Journal of surgical research·2026
Same author

Risk stratification by donor-derived cell-free DNA: a three-year single center study of kidney transplant outcomes from 257 patients.

Frontiers in immunology·2026
Same author

Plain Chest Film Versus Computed Tomography of the Chest as the Initial Imaging Modality for Blunt Thoracic Injury.

The American surgeon·2024
Same author

Challenging Dogma by Skipping the Emergency Department Thoracotomy: A Propensity Score Matched Analysis of the Trauma Quality Improvement Database.

The Journal of surgical research·2024
Same author

The ICD-9 to ICD-10 transition has not improved identification of rapidly progressing stage 3 and stage 4 chronic kidney disease patients: a diagnostic test study.

BMC nephrology·2024
Same journal

Impact of Postpandemic Pediatric Infection Rebound on Febrile Seizures: A Nationwide Cohort Study, 2013-2023.

Pediatric neurology·2026
Same journal

The Hidden Cost of Developmental and Epileptic Encephalopathy in Australia: Caregiver Quality of Life, Sleep, Depression, and Workforce Participation.

Pediatric neurology·2026
Same journal

A Novel Neonatal Brain Injury Score for Infants With Congenital Diaphragmatic Hernia.

Pediatric neurology·2026
Same journal

Clinical and Functional Severity of Cerebral Palsy in a Tertiary Referral Cohort From Northeast Brazil: Insights From a Middle-Income Country.

Pediatric neurology·2026
Same journal

Small-Fiber Neuropathy in an Adolescent With Prader-Willi Syndrome.

Pediatric neurology·2026
Same journal

Research of Tuberous Sclerosis Complex (TSC)-Associated Neuropsychiatric Disorders (TAND) in China.

Pediatric neurology·2026
See all related articles

Related Experiment Video

Updated: May 17, 2026

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
07:45

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy

Published on: October 21, 2014

Does galactocerebrosidase activity predict Krabbe phenotype?

Kabir Jalal1, Randy Carter, Li Yan

  • 1Department of Biostatistics, Population Health Observatory, School of Public Health and Health Professions, State University of New York at Buffalo, Buffalo, New York, USA.

Pediatric Neurology
|October 10, 2012
PubMed
Summary
This summary is machine-generated.

Higher galactocerebrosidase activity predicts later Krabbe disease onset but not survival. Early infantile Krabbe disease cases showed no galactocerebrosidase activity above 0.1 nmol/hour/mg protein, suggesting its importance in newborn screening.

More Related Videos

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
10:16

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

Published on: December 20, 2017

Methods to Assess Subcellular Compartments of Muscle in C. elegans
10:13

Methods to Assess Subcellular Compartments of Muscle in C. elegans

Published on: November 13, 2014

Related Experiment Videos

Last Updated: May 17, 2026

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
07:45

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy

Published on: October 21, 2014

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
10:16

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

Published on: December 20, 2017

Methods to Assess Subcellular Compartments of Muscle in C. elegans
10:13

Methods to Assess Subcellular Compartments of Muscle in C. elegans

Published on: November 13, 2014

Area of Science:

  • Biochemistry
  • Genetics
  • Neurology

Background:

  • Krabbe disease is a rare, fatal neurodegenerative disorder.
  • Galactocerebrosidase (GALC) enzyme activity is a key biomarker for Krabbe disease.
  • Predicting Krabbe disease onset and progression is crucial for early intervention.

Purpose of the Study:

  • To investigate if galactocerebrosidase activity predicts Krabbe disease onset age.
  • To determine if galactocerebrosidase activity predicts survival after Krabbe disease onset.
  • To evaluate the utility of galactocerebrosidase activity in newborn screening for Krabbe disease.

Main Methods:

  • Analysis of data from 55 symptomatic Krabbe disease patients.
  • Measurement of galactocerebrosidase activity using established biochemical assays.
  • Application of survival models within a path analysis framework.

Main Results:

  • Increased galactocerebrosidase activity was significantly associated with later symptom onset (P = 0.0011).
  • Galactocerebrosidase activity did not predict survival time after symptom onset (P = 0.9064).
  • No early infantile Krabbe disease cases (0-6 months) exhibited GALC activity >0.1 nmol/hour/mg protein.

Conclusions:

  • Galactocerebrosidase activity is a predictor of later Krabbe disease onset.
  • Galactocerebrosidase activity levels may help refine Krabbe disease phenotype prediction in newborns.
  • The threshold of 0.15 nmol/hour/mg protein for high-risk GALC activity in newborn screening appears appropriate.